abagovomab fails placebo phase111 trial, page-25

abdm

I agree for the most part. But that was done to cover his tracks. And therefore nothing altruistic about it. Kind of sad seeing someone backpedalling at 100mph - more so when their initial premise is based on false findings.

The fact Ab was rejected is based upon that scientific method. Bad for them, sad for patients, good for C-Vac.

Unmet remains unmet and that is one of the critical factors C-Vac has going for it.

If the FDA in their "infinite wisdom" vote against C-Vac, then I tell you, it will be a sham of the highest order.